Why skin deposition is the next frontier. Explore how the NanoBase™ nano-colloidal Architecture is designed for stability, and where it sits next to traditional SLNs and NLCs; any deposition claim belongs to the finished formula.

Most modern skincare is still built on 1950s emulsion logic. We are breaking that bottleneck with NanoBase™, a tri-domain nano-colloidal Architecture engineered to a ~185 nm design target and DLS-characterised every batch, built for the biotech era. Discover why formula architecture matters.